[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.82.105. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
August 27, 2014

Self-titration of Antihypertensive Therapy in High-Risk PatientsBringing It Home

Author Affiliations
  • 1Department of Clinical Sciences, Lund University, Skåne University Hospital, Sweden
  • 2Department of Medical and Health Sciences, Linköping University, Linköping, Sweden
JAMA. 2014;312(8):795-796. doi:10.1001/jama.2014.10058

Hypertension is a common cause of premature mortality yet has been amenable to pharmacologic treatment for more than 8 decades. Resting blood pressure fluctuates for various reasons, and individual responses to different classes of antihypertensive drugs vary considerably. In another high-risk common chronic condition, diabetes, glucose levels vary widely due to factors including individual drug response, physical activity, and carbohydrate intake. Patients treated with insulin are generally taught to adjust their insulin dose guided by self-measurement of glucose levels.

First Page Preview View Large
First page PDF preview
First page PDF preview
×